Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).

JACC: Heart Failure

Volumn 1, Issue 6, 2013, Pages 500-507

  Gasparini, Maurizio ^a   Leclercq, Christophe ^b   Lunati, Maurizio ^c   Landolina, Maurizio ^d   Auricchio, Angelo ^e   Santini, Massimo ^f   Boriani, Giuseppe ^g   Lamp, Barbara ^h   Proclemer, Alessandro ⁱ   Curnis, Antonio ^j   Klersy, Catherine ^d   Leyva, Francisco ^k  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e DIVISION OF CARDIOLOGY   (Switzerland)

^f SAN FILIPPO NERI HOSPITAL   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^j Cardiology Department   (Italy)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

more..

Author keywords

Ablation of atrioventricular junction; Atrial fibrillation; Cardiac resynchronization therapy; Heart failure

Indexed keywords

AMIODARONE; DIGOXIN; ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; AGED; ARTICLE; ATRIOVENTRICULAR JUNCTION ABLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SINUS RHYTHM; SURVIVAL TIME; TREATMENT OUTCOME; ATRIAL FIBRILLATION; CATHETER ABLATION; CLINICAL TRIAL; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84889021338     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.06.003     Document Type: Article

References (34)

1. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. NEngl J Med 2002, 346:1845-1853.
2. Cazeau S., Leclercq C., Lavergne T., et al. The Multisite Stimulation in Cardiomyopathies Study I. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. NEngl J Med 2001, 344:873-880.
3. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. JAm Coll Cardiol 2002, 40:111-118.
4. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. NEngl J Med 2005, 352:1539-1549.
5. St.John Sutton M.G., Plappter T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985-1990.
6. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. NEngl J Med 2004, 350:2140-2150.
7. Carson P.E., Johnson G.R., Dunkman W.B., et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87(Suppl 6):VII02-VII10.
8. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003, 107:2920-2925.
9. Santini M., Gasparini M., Landolina M., et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. JAm Coll Cardiol 2011, 57:167-172.
10. Khadjooi K., Foley P.W., Chalil S., et al. Long-term effects of cardiac resynchronization therapy in patients with atrial fibrillation. Heart 2008, 94:879-883.
11. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. JAm Coll Cardiol 2006, 48:734-743.
12. Gasparini M., Auricchio A., Metra M., et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008, 29:1644-1652.
13. Gasparini M., Steinberg J.S., Arshad A., et al. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J 2010, 31:976-983.
14. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004, 94:1506-1509.
15. Leclercq C., Walker S., Linde C., et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002, 23:1780-1787.
16. Maisel W.H., Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003, 91:2D-8D.
17. Leon A.R., Greenberg J.M., Kanuru N., et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. JAm Coll Cardiol 2002, 39:1258-1263.
18. Epstein A.E., Carlson M.D., Fogoros R.N., et al. Classification of death in antiarrhythmia trials. JAm Coll Cardiol 1996, 27:433-442.
19. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
20. Wyse D.G., Waldo A.L., DiMarco J.P., et al. Acomparison of rate control and rhythm control in patients with atrial fibrillation. NEngl J Med 2002, 347:1825-1833.
21. Bax J.J., Abraham T., Barold S.S., et al. Cardiac resynchronization therapy: part 2-issues during and after device implantation and unresolved questions. JAm Coll Cardiol 2005, 46:2168-2182.
22. Auricchio A., Metra M., Gasparini M., et al. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Am J Cardiol 2007, 99:232-238.
23. Dickstein K., Bogale N., Priori S., et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009, 30:2450-2460.
24. Delnoy P.P., Ottervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007, 99:1252-1257.
25. Upadhyay G.A., Choudhry N.K., Auricchio A., Ruskin J., Singh J.P. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. JAm Coll Cardiol 2008, 52:1239-1246.
26. Ganesan A.N., Brooks A.G., Roberts-Thomson K.C., Lau D.H., Kalman J.M., Sanders P. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure: a systematic review. JAm Coll Cardiol 2012, 59:719-726.
27. McMurray J.J.V., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 2012, 33:1787-1847.
28. Tracy C.M., Epstein A.E., Darbar D., et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2012, 60:1297-1313.
29. Koplan B.A., Kaplan A.J., Weiner S., Jones P.W., Seth M., Christman S.A. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?. JAm Coll Cardiol 2009, 53:355-360.
30. Hayes D.L., Boehmer J.P., Day J.D., et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011, 8:1469-1475.
31. Healey J.S., Hohnloser S.H., Exner D.V., et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail 2012, 5:566-570.
32. Gasparini M., Galimberti P. AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: the picture is now clear!. J Am Coll Cardiol 2012, 59:727-729.
33. Kies P., Leclercq C., Bleeker G.B., et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006, 92:490-494.
34. Kamath G.S., Cotiga D., Koneru J.N., et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of non-responders following cardiac resynchronization therapy. JAm Coll Cardiol 2009, 53:1050-1055.